UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date:
January 11, 2021
Accession Number:
Submission Type:
CIK:
0001348362
Company Name:
Lexaria Bioscience Corp.
File Number:
333-250326